Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 505, pseudogene (RN7SL505P)

Target
RN7SL505P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RN7SL505P (RNA, 7SL, cytoplasmic 505, pseudogene) is a **pseudogene** of the 7SL RNA family, which originally encodes a non-coding RNA component of the signal recognition particle (SRP) involved in cytoplasmic protein targeting and translation regulation[1][6]. The majority of 7SL-like sequences in the human genome are pseudogenes, derived from the reverse transcription of 7SL RNA back into the genome[5]. RN7SL505P is one such truncated, non-functional copy and does not encode a functional RNA or protein product, nor is it known to serve as a direct therapeutic, diagnostic, or research target[5][6]. There is no evidence that RN7SL505P plays a role in disease, drug interaction, or cellular biology, and it lacks canonical biological activity. By convention, pseudogenes are not considered classical molecular targets for drug development, but they can occasionally play indirect roles in gene regulation (for example, by acting as microRNA sponges); however, no such roles are reported for RN7SL505P[4][5][6]. **Key Points:** - RN7SL505P is a **non-functional** pseudogene of 7SL RNA, not an active gene or protein. - No role is currently established in biology, disease, or therapy for this specific pseudogene. - Listing as a target is likely incorrect or reflects a misunderstanding of nomenclature; this is not a druggable or functional protein, enzyme, or receptor[6][5].

Other names
7SL RNA pseudogene 5057SL RNA, cytoplasmic 505, pseudogeneRN7SL505P
02

Biological functions

None (pseudogenes generally lack protein-coding or canonical regulatory function; see details below)
03

Disease associations

None established for RN7SL505P (see description for general context)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 505, pseudogene (RN7SL505P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 505, pseudogene (RN7SL505P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call